David Killock
Impact in
- Health Informatics top 10%
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 90
- Cancer Immunotherapy and Biomarkers 27
- CAR-T cell therapy research 26
- Colorectal Cancer Treatments and Studies 15
- Co-authors
- Aleksandar Ívetic (6 shared papers)Maddy Parsons (2 shared papers)Marketa Zvelebil (1 shared paper)Dorian O. Haskard (1 shared paper)Marouan Zarrouk (2 shared papers)Simon Ameer‐Beg (1 shared paper)Anne J. Ridley (1 shared paper)María‐Jesús Sanz (1 shared paper)
- Journals
- Nature Reviews Clinical Oncology (188 papers)Nature Reviews Rheumatology (19 papers)Nature Reviews Urology (6 papers)Blood (1 paper)Journal of Cell Science (1 paper)
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
David Killock
203 papers receiving 912 citations
Peers
Comparison fields: 5 of 105
- Health Informatics 20
- Oncology 309
- Immunology and Allergy 65
- Cancer Research 131
- Immunology 191
Countries citing papers authored by David Killock
This map shows the geographic impact of David Killock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Killock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Killock more than expected).
Fields of papers citing papers by David Killock
This network shows the impact of papers produced by David Killock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Killock. The network helps show where David Killock may publish in the future.
Co-authors
The 25 scholars most cited alongside David Killock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 219 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 71 | |
| 2 | 2020 | 51 | |
| 3 | 2009 | 39 | |
| 4 | 2018 | 33 | |
| 5 | 2021 | 30 | |
| 6 | 2015 | 29 | |
| 7 | 2015 | 18 | |
| 8 | 2017 | 18 | |
| 9 | 2015 | 15 | |
| 10 | 2016 | 14 | |
| 11 | 2017 | 14 | |
| 12 | 2010 | 13 | |
| 13 | 2017 | 13 | |
| 14 | 2016 | 12 | |
| 15 | 2021 | 12 | |
| 16 | 2015 | 12 | |
| 17 | 2015 | 11 | |
| 18 | 2023 | 10 | |
| 19 | 2021 | 10 | |
| 20 | 2012 | 10 |
About David Killock
David Killock is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Genetics, having authored 219 papers that have together received 925 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (27 papers), CAR-T cell therapy research (26 papers), Chronic Lymphocytic Leukemia Research (19 papers), Cancer Genomics and Diagnostics (18 papers), Lung Cancer Treatments and Mutations (16 papers), Lymphoma Diagnosis and Treatment (16 papers), Colorectal Cancer Treatments and Studies (15 papers) and Chronic Myeloid Leukemia Treatments (12 papers). The work is most often cited by research in Health Informatics (20 citations), Oncology (309 citations), Immunology and Allergy (65 citations), Cancer Research (131 citations) and Immunology (191 citations). David Killock has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Aleksandar Ívetic, Maddy Parsons, Marketa Zvelebil, Dorian O. Haskard, Marouan Zarrouk, Simon Ameer‐Beg, Anne J. Ridley, María‐Jesús Sanz, Hannah L.H. Green and Justin Joachim. Their work appears in journals such as Nature Reviews Clinical Oncology, Nature Reviews Rheumatology, Nature Reviews Urology, Blood and Journal of Cell Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.